James W Wheless
Affiliations: | Neuroscience Institute | University of Tennessee Health Science Center, Memphis, TN, United States |
Google:
"James Wheless"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chourasia N, Dohmeier J, Curry J, et al. (2024) Clinical Experience With Lacosamide as an Adjunct Treatment for Neonatal Seizures: A Retrospective Single-Center Study. Pediatric Neurology. 157: 134-140 |
| Misra SN, Sperling MR, Rao VR, et al. (2024) Analyses of patients who self-administered diazepam nasal spray for acute treatment of seizure clusters. Epilepsy & Behavior Reports. 25: 100644 |
| Gidal BE, Resnick T, Smith MC, et al. (2023) Zonisamide: A Comprehensive, Updated Review for the Clinician. Neurology. Clinical Practice. 14: e200210 |
| Perry MS, Scheffer IE, Sullivan J, et al. (2023) Severe Communication Delays Are Independent of Seizure Burden and Persist Despite Contemporary Treatments in SCN1A+ Dravet Syndrome: Insights from the ENVISION Natural History Study. Epilepsia |
| Wheless JW, Gidal B, Rabinowicz AL, et al. (2023) Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs. Paediatric Drugs |
| Becker DA, Wheless JW, Sirven J, et al. (2023) Treatment of Seizure Clusters in Epilepsy: A Narrative Review on Rescue Therapies. Neurology and Therapy |
| Wheless J, Chourasia N. (2022) Safety evaluation of perampanel as monotherapy or first adjunctive therapy in patients with epilepsy. Expert Opinion On Drug Safety. 21: 1239-1247 |
| Yamamoto T, Gil-Nagel A, Wheless JW, et al. (2022) Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidence. Epilepsy & Behavior : E&B. 136: 108885 |
| Northrup H, Aronow ME, Bebin EM, et al. (2021) Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatric Neurology. 123: 50-66 |
| Cascino GD, Tarquinio D, Wheless JW, et al. (2021) Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study. Epilepsy & Behavior : E&B. 120: 107983 |